ER stress and the UPR play significant roles in the development and progression of various cancers. Tumor cells often experience increased ER stress due to their rapid proliferation and the harsh tumor microenvironment, which includes factors like hypoxia and nutrient deprivation. The activation of the UPR in cancer cells can contribute to both tumor growth and resistance to therapies.
